1. Home
  2. TEN vs TBPH Comparison

TEN vs TBPH Comparison

Compare TEN & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEN
  • TBPH
  • Stock Information
  • Founded
  • TEN 1993
  • TBPH 2013
  • Country
  • TEN Greece
  • TBPH United States
  • Employees
  • TEN N/A
  • TBPH N/A
  • Industry
  • TEN
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TEN
  • TBPH Health Care
  • Exchange
  • TEN NYSE
  • TBPH Nasdaq
  • Market Cap
  • TEN 480.8M
  • TBPH 464.5M
  • IPO Year
  • TEN N/A
  • TBPH N/A
  • Fundamental
  • Price
  • TEN $17.51
  • TBPH $8.98
  • Analyst Decision
  • TEN Buy
  • TBPH Buy
  • Analyst Count
  • TEN 2
  • TBPH 3
  • Target Price
  • TEN $31.00
  • TBPH $11.33
  • AVG Volume (30 Days)
  • TEN 257.9K
  • TBPH 253.4K
  • Earning Date
  • TEN 05-23-2025
  • TBPH 05-08-2025
  • Dividend Yield
  • TEN 8.56%
  • TBPH N/A
  • EPS Growth
  • TEN N/A
  • TBPH N/A
  • EPS
  • TEN 5.03
  • TBPH N/A
  • Revenue
  • TEN $804,061,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • TEN N/A
  • TBPH $51.09
  • Revenue Next Year
  • TEN $11.19
  • TBPH N/A
  • P/E Ratio
  • TEN $3.42
  • TBPH N/A
  • Revenue Growth
  • TEN N/A
  • TBPH 6.11
  • 52 Week Low
  • TEN $13.40
  • TBPH $7.44
  • 52 Week High
  • TEN $31.48
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • TEN 58.95
  • TBPH 41.09
  • Support Level
  • TEN $17.02
  • TBPH $9.90
  • Resistance Level
  • TEN $17.73
  • TBPH $10.55
  • Average True Range (ATR)
  • TEN 0.57
  • TBPH 0.36
  • MACD
  • TEN 0.14
  • TBPH -0.02
  • Stochastic Oscillator
  • TEN 78.47
  • TBPH 15.82

About TEN TSAKOS ENERGY NAVIGATION

Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: